Fig. 5From: Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cellsEffect on foam cell formation. Foam cell formation with vehicle (a) and myricetin (b) treated macrophages with ox-LDLincubation. ox-LDL uptake (c) and BODIPY intensity (d) by flow-cytometry in cholesterol load macrophages. e Lipid accumulation in vehicle and myricetin treated macrophages. Values are expressed as mean ± SD. *P < 0.05,**P < 0.005 for Myricetin vs. VehicleBack to article page